Inventor · disambiguated record
Leticia M. Toledo-Sherman
Also filed as: TOLEDO-SHERMAN LETICIA · TOLEDO-SHERMAN LETICIA M
20 granted patents·5 pending applications·197 citations·filing 2000–2020
94Inventor score
Top patents by PatentIndex Score
25 records- 0198US7282504B2Kinase inhibitorsAMGEN INC·Filed 2005·Granted Oct 16, 2007·90 cites·11 claims
- 0289US7074789B2Kinase inhibitorsAMGEN INC·Filed 2003·Granted Jul 11, 2006·25 cites·7 claims
- 0387US9428464B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCOURTNEY STEPHEN MARTIN·Filed 2012·Granted Aug 30, 2016·14 cites·3 claims
- 0487US6495558B1Kinase inhibitorsAMGEN INC·Filed 2000·Granted Dec 17, 2002·18 cites·5 claims
- 0586US8883785B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofDOMINGUEZ CELIA·Filed 2011·Granted Nov 11, 2014·15 cites·13 claims
- 0684US8536186B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofWITYAK JOHN·Filed 2009·Granted Sep 17, 2013·9 cites·6 claims
- 0783US9260422B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofDOMINGUEZ CELIA·Filed 2012·Granted Feb 16, 2016·7 cites·10 claims
- 0882US9145373B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofWITYAK JOHN·Filed 2013·Granted Sep 29, 2015·7 cites·9 claims
- 0978US9884853B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2014·Granted Feb 6, 2018·3 cites·16 claims
- 1077US9822058B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2013·Granted Nov 21, 2017·3 cites·24 claims
- 1176US9938252B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2014·Granted Apr 10, 2018·2 cites·2 claims
- 1274US10442782B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2017·Granted Oct 15, 2019·1 cites·21 claims
- 1371US9649310B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2016·Granted May 16, 2017·1 cites·12 claims
- 1468US9981918B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofTOLEDO SHERMAN LETICIA M·Filed 2012·Granted May 29, 2018·2 cites·3 claims
- 1555US10501433B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2018·Granted Dec 10, 2019·0 cites·4 claims
- 1653US11685734B2ATM kinase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2020·Granted Jun 27, 2023·0 cites·35 claims
- 1753US11173156B2Solid forms of a kynurenine-3-monooxygenase inhibitorCHDI FOUNDATION INC·Filed 2020·Granted Nov 16, 2021·0 cites·10 claims
- 1853US2007213378A1Compounds for modulating cell proliferation, compositions and methods related theretoLYMPHOSIGN INC·Filed 2007·Application pending·0 cites
- 1952US2011230428A1Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofWITYAK JOHN·Filed 2009·Application pending·0 cites
- 2052US2003199534A1Kinase inhibitorsAMGEN INC·Filed 2003·Application pending·0 cites
- 2151US10428054B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2017·Granted Oct 1, 2019·0 cites·17 claims
- 2250US8691824B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofWITYAK JOHN·Filed 2009·Granted Apr 8, 2014·0 cites·20 claims
- 2348US2003004174A9Kinase inhibitorsFiled 2001·Application pending·0 cites
- 2447US2004019067A1Kinase inhibitorsAMGEN INC·Filed 2002·Application pending·0 cites
- 2537US10258621B2Methods and compositions for treating HIV-related disordersCHDI FOUNDATION INC·Filed 2015·Granted Apr 16, 2019·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →